Short answer
STAAR SURGICAL CO (STAA) filed its Q4 2026 10-Q quarterly report on Nov 4, 2026 for the quarter ended Oct 2, 2026. Quarterly revenue was $83M (down 12.0% year over year) with net income of $6M.
Q4 2026 key financials · XBRL
- Revenue
- $83M
- −12.0% YoY · −10.8% QoQ
- Net income
- $6M
- −37.2% YoY · −30.8% QoQ
- Operating margin
- 6.5%
- Gross margin
- 70.9%
- EPS (diluted)
- $0.11
- −38.9% YoY · −31.3% QoQ
Source: XBRL data from the STAAR SURGICAL CO (STAA) Q4 2026 10-Q on SEC EDGAR. USD.
STAAR SURGICAL CO Q4 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Q3 revenue $83.4M, down 12% YoY, or up 21.1% excluding $25.9M December China Shipment
- Gross margin 70.9% vs 82.2% YoY, pressured by ERP-related costs, freight, tariffs and inventory provisions
- EMEA best-performing region, sales up 31%; APAC weakest, sales down 20% from China shipment effects
- Cash and investments $206.4M, up from $181.5M sequentially; nine-month operating cash flow $25.3M vs $(30.3)M
- 2026 gross-margin target of 75% not expected; fourth-quarter improvement anticipated, with ERP and tariff headwinds persisting
Risk Factors
- No material changes disclosed from the January 2, 2026 Form 10-K
- Carried-forward risk: External factors could materially adversely affect business, financial condition, or operating results
- No new regulatory, operational, competitive, or financial risks identified in the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other STAAR SURGICAL CO quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.